RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 128.51 Million USD | -11.17% |
| 2021 | 144.67 Million USD | -61.0% |
| 2020 | 370.94 Million USD | -19.93% |
| 2019 | 463.25 Million USD | -43.99% |
| 2018 | 827.14 Million USD | -10.07% |
| 2017 | 919.74 Million USD | -6.01% |
| 2016 | 978.5 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 111.1 Million USD | -13.54% |
| 2023 Q2 | 85.4 Million USD | -23.13% |
| 2022 Q3 | 155.35 Million USD | 24.45% |
| 2022 Q2 | 124.83 Million USD | -13.5% |
| 2022 FY | 128.51 Million USD | -11.17% |
| 2022 Q1 | 144.3 Million USD | -7.08% |
| 2022 Q4 | 128.51 Million USD | -17.28% |
| 2021 Q4 | 155.3 Million USD | 41.77% |
| 2021 FY | 144.67 Million USD | -61.0% |
| 2021 Q3 | 109.54 Million USD | 0.0% |
| 2020 FY | 370.94 Million USD | -19.93% |
| 2019 FY | 463.25 Million USD | -43.99% |
| 2018 FY | 827.14 Million USD | -10.07% |
| 2017 FY | 919.74 Million USD | -6.01% |
| 2016 FY | 978.5 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -5563103.463% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -6462.696% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -1117.643% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -23175.737% |
| Rebus Holdings, Inc. | 5000.00 USD | -2570100.0% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 1.306% |
| Qrons Inc. | 420.00 USD | -30597519.048% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -16575.663% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -359.884% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -26641.885% |
| Skye Bioscience, Inc. | 11.94 Million USD | -976.261% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -230.811% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -1679.976% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -168208.144% |
| SQZ Biotechnologies Company | 107.18 Million USD | -19.893% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -8873.961% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -177485.85% |
| Mesoblast Limited | 667.9 Million USD | 80.759% |
| Marizyme, Inc. | 22.01 Million USD | -483.736% |
| Genus plc | 1.02 Billion USD | 87.51% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -9360.722% |
| Pharming Group N.V. | 462.85 Million USD | 72.235% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -3778.948% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -25651.494% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -20396.013% |
| ContraFect Corporation | 20.67 Million USD | -521.452% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -32820.388% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -33525.781% |
| IMV Inc. | 31.33 Million USD | -310.132% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -2999.598% |
| MultiCell Technologies, Inc. | 126.22 USD | -101814192.505% |
| ONE Bio Corp. | 70.08 Million USD | -83.362% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -13575.801% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -29667.392% |
| Q BioMed Inc. | 3.51 Million USD | -3555.508% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -265.303% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -49085.347% |
| Biomind Labs Inc. | 73.81 Thousand USD | -173987.972% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 71.206% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -8769.836% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -328.153% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -4579.327% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -18592.744% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -4836.624% |
| GB Sciences, Inc. | 103.44 Thousand USD | -124133.87% |
| Alpha Cognition Inc. | 2.45 Million USD | -5140.664% |
| HST Global, Inc. | 1526.00 USD | -8421263.041% |
| CSL Limited | 38.02 Billion USD | 99.662% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -12907.519% |
| Halberd Corporation | 10.13 Thousand USD | -1268382.874% |
| Enzolytics Inc. | 361.7 Million USD | 64.471% |
| Agentix Corp. | 261.39 Thousand USD | -49063.708% |
| Resverlogix Corp. | 8.11 Million USD | -1483.611% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -6743.355% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 97.171% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -169.402% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -19990.486% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -564010.443% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -1336.001% |
| AVAX Technologies, Inc. | 7.37 Million USD | -1641.999% |
| Zenith Capital Corp. | 7410.00 USD | -1734178.003% |
| Genscript Biotech Corporation | 3.38 Billion USD | 96.205% |
| Ember Therapeutics, Inc. | 184.00 USD | -69842291.304% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -39833.998% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -49068.975% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -13748.642% |
| Kadimastem Ltd | 2.3 Million USD | -5477.497% |
| Helix BioMedix, Inc. | 3.02 Million USD | -4148.144% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -143.847% |
| BioStem Technologies, Inc. | 14.56 Million USD | -782.606% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -224984.948% |
| LadRx Corporation | 2.3 Million USD | -5468.309% |
| Cell Source, Inc. | 195.17 Thousand USD | -65744.823% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -36241.579% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -36241.579% |
| NovAccess Global Inc. | 62.24 Thousand USD | -206348.4% |
| Affymax, Inc. | 7.44 Million USD | -1626.589% |
| Itoco Inc. | 1.4 Million USD | -9078.814% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -134244.585% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -121135.849% |
| Mobile Lads Corp. | 52.00 USD | -247134515.385% |
| CytoDyn Inc. | 11.13 Million USD | -1054.005% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -89784.733% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -718636.018% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -33238.435% |
| SYBLEU INC | 330.46 Thousand USD | -38787.275% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -31288.152% |
| International Stem Cell Corporation | 5.39 Million USD | -2284.23% |
| Bioxytran, Inc. | 137.63 Thousand USD | -93268.111% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -756.629% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -675.137% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -162570.886% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -14762.197% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -1609.592% |
| Neutra Corp. | 2851.00 USD | -4507441.214% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -296.562% |
| PureTech Health plc | 693.97 Million USD | 81.482% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -1492.226% |
| IXICO plc | 15.84 Million USD | -711.101% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -1451.678% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -24.376% |
| CSL Limited | 38.02 Billion USD | 99.662% |
| Cellectis S.A. | 333.99 Million USD | 61.523% |